EN DE

Science Group (SAG) Fair Value & Analysis

Industrials · GB · Market cap 238M GBX

SG Science Group SAG · LSE
Price£5.85
Fair Value£8.63
Upside+47.5%
Quality79/100
Watch Science Group for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Highly profitable · 29.8% net margin
Low debt · generates free cash flow
1.71% dividend yield
Mixed vs. peers (8/15)
Wide moat 74/100
Evidence: High Range £6.84 – £14.57 Share as image

Fair value as of: Jul 16, 2026

From 26 valuation models · updated 25 days ago

Fair value updated Jul 16, 2026, revised from £8.58 to £8.63 (+0.6%) since Jun 24, 2026. Share price −0.3% over the past month.

A strong business, screening 48% undervalued on our models.

What matters now

  • The rarer combination: high quality (79/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case (£6.84). The market is more pessimistic than our downside scenario.
  • A fairly wide model range (£6.84 to £14.57) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

£6.04 £3.22 Fair Value £8.63 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range £3.22 – £6.04 · fair‑value band £6.84 – £14.57 · the £5.85 price screens below the £8.63 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Science Group (SAG) currently trades at £5.85, while our model-based Fair Value estimate is £8.63, implying the stock looks roughly 47.5% undervalued today. The Quality Score stands at 79/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Science Group generated revenue of £112M at a net margin of 29.8%. Revenue declined 4.4% year over year. It earns a return on equity of 35.5%. The balance sheet holds a net cash position of £60.8M. Fundamentals as of Jul 16, 2026

Our scenario range runs from £6.84 (bear case) to £14.57 (bull case); at £5.85, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Industrials peers we cover trades at -15% fair-value upside, at 48%, SAG screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF £6.96 £9.56 £12.94 80
Residual Income £4.60 £6.98 £53.93 76
Rev-Margin DCF £5.78 £8.15 £11.14 74
All 26 models by family
DCF Models
FCF DCF £7.04 £10.00 £14.13 38
Owner Earnings £10.19 £14.86 £21.36 31
5Y Revenue Exit £5.78 £8.13 £11.17 39
5Y EBITDA Exit £6.65 £9.88 £13.79 41
5Y P/E Exit £10.61 £17.85 £25.99 38
10Y Revenue Exit £6.16 £8.33 £11.39 36
10Y EBITDA Exit £6.73 £9.41 £13.22 37
10Y P/E Exit £8.96 £14.33 £21.74 35
Earnings-Based
Graham-Dodd £5.56 £23.81 £32.53 54
Lynch FV £6.09 £8.70 £11.31 50
PEG = 1.0 £6.09 £8.70 £11.31 46
EPV £3.09 £3.28 £3.42 59
Dividend Discount
Gordon GGM £0.6100 £1.02 £1.33 70
DDM Multi-Stage £0.6100 £0.9700 £1.10 61
Multiples
P/E Multiple £12.87 £17.16 £21.45 63
P/S Multiple £4.11 £5.48 £6.86 58
P/B Multiple £8.56 £11.42 £14.27 55
EV/EBIT £6.86 £8.62 £10.38 53
EV/EBITDA £6.93 £8.71 £10.50 54
EV/Revenue £5.03 £6.51 £7.99 43
Asset-Based
NCAV (Graham) £1.27 £1.70 £2.54 50
Growth DCF
Growth DCF £6.96 £9.56 £12.94 80
Rev-Margin DCF £5.78 £8.15 £11.14 74
Economic Profit
Residual Income £4.60 £6.98 £53.93 76
ROIC Compounder £3.21 £3.58 £4.00 72
Growth Earnings
Growth-Adj P/E £10.21 £14.59 £18.97 68

Widest divergence: Growth Earnings (£14.59) versus Dividend Discount (£0.9700). Highest evidence: Growth DCF (80).

Notify me when SAG reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 112M GBX
Revenue growth (YoY) -4.4%
Net margin 29.8%
Return on equity 35.5%
Free cash flow 24.6M GBX FY2025
P/E ratio 7.8
More key figures
Operating margin 16.2%
EPS (TTM) £0.7400
Dividend yield 1.7%
EPS growth (YoY) +45.4%
Net cash 60.8M GBX FY2025

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 79/100

Of which business quality 78 · Market factors (momentum, volatility) 63

Profitability 80
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 98
Balance sheet, leverage, solvency risk
Investment 69
Disciplined investing over empire-building
Low Volatility 93
Calm price path (market factor)
Momentum 46
Price trend over the last 3–12 months (market factor)
52W Momentum 59
Distance to the 52-week high (market factor)
Net Issuance 97
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Science Group plc, a services and systems company, operates in the science, technology, and engineering applications in the United Kingdom, rest of European Countries, North America, Asia, and internationally. The company offers advisory, product development, and regulatory services.

Full company description

Science Group plc, a services and systems company, operates in the science, technology, and engineering applications in the United Kingdom, rest of European Countries, North America, Asia, and internationally. The company offers advisory, product development, and regulatory services. It is also involved in the design, development, and manufacture of submarine atmosphere management systems; and design and supply of radio and audio semi-conductors/modules. In addition, the company provides property, production, and consultancy services. It serves industrial, defense and aerospace, medical, and consumer sectors. The company was formerly known as Sagentia Group plc and changed its name to Science Group plc in July 2015. Science Group plc was incorporated in 2008 and is headquartered in Cambridge, the United Kingdom.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Science Group reported revenue of £112M in FY2025 versus £81.2M in FY2021, a compound +8.3%/yr. Reported net income was £33.3M in FY2025, compounding +36.6%/yr from FY2021.

Growth Quality 88/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
£112M
Latest YoY
+0.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.7%
Avg. growth/yr (21Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.2%
Revenue +8.3%/yr
FY21 £81.2M
FY22 £86.3M
FY23 £113M
FY24 £111M
FY25 £112M
Net income +36.6%/yr
FY21 £9.6M
FY22 £10.6M
FY23 £5.5M
FY24 £12.0M
FY25 £33.3M
Character of growth · EPS growth decomposed (2014-2025) +20.0 % p.a.
Revenue per share +13.7 pp

of which total revenue +14.9 pp · buybacks/dilution −1.2 pp

EBIT margin +0.7 pp
Tax rate −1.8 pp
Residual (interest, one-offs) +7.4 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch SAG: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Science Group Fair Value". https://www.fairvalue-calculator.com/stock/SAG

Peer Group

Consulting Services · 82 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 79 · Top 25%
Fair Value upside +48% · Top 25%
Return on equity (TTM) 36% · Top 25%
Return on assets 7% · Above median
Net margin (TTM) 30% · Top 25%
Operating margin (TTM) 16% · Above median
Revenue growth -4% · Below median
Dividend yield (TTM) 1.7% · Below median
Debt / equity 0.11× · Lower than median

Valuation Multiples vs Consulting Services median · lower = cheaper

P/E (TTM) 7.9× · Cheaper than 75% of peers
P/B 3.11× · Pricier than median
P/S (TTM) 2.88× · Pricier than median
P/FCF 13.1× · Pricier than median
EV/EBITDA 12.0× · Pricier than median
PEG 1,017.63× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 97 · sector 20
FUTURE 0 · sector 14
PAST 100 · sector 40
HEALTH 95 · sector 89
DIVIDEND 34 · sector 49

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Verisk Analytics, Inc VRSK $201.49 $145.58 -28%
SGS SA SGSN CHF 94.68 CHF 68.96 -27%
Equifax Inc EFX $177.08 $101.34 -43%
Bureau Veritas SA BVI €27.20 €27.81 +2%
ALS Limited ALQ A$21.96 A$11.02 -50%
Booz Allen Hamilton Holding BAH $63.94 $120.62 +89%
DKSH Holding DKSH CHF 67.60 CHF 64.81 -4%
FTI Consulting, Inc FCN $156.86 $171.64 +9%
Centre Testing International Group 300012 ¥14.06 ¥11.90 -15%
GRG Metrology & Test Group 002967 ¥16.56 ¥11.69 -29%

Compare Science Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Science Group (SAG) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of £8.63 versus a price of £5.85, about +48% (undervalued).
What is the fair value of SAG?
Our model-based fair value for Science Group is £8.63 (as of Jul 16, 2026), built from audited fundamentals. The current price is £5.85.
What is the quality score of SAG?
Science Group has a Quality Score of 79/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Science Group (SAG)?
Science Group reported trailing-twelve-month revenue of about £112M (latest available figure, as of Jul 16, 2026).
What is the net profit margin of SAG?
The net profit margin of Science Group is about 29.8%, meaning it keeps roughly 29.8% of revenue as net income. Based on the latest reported figures.
Does Science Group pay a dividend?
Science Group currently shows a dividend yield of about 1.72% relative to its recent price (as of Jul 16, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Science Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.